Caxton Associates (UK)’s Insulet PODD Stock Holding History

Caxton Associates (UK)’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,382	Closed	-$290K	–	929
2026 Q1	$290K	Buy	+1,382	New	+$347K	0.01%	616

Other funds holding PODD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Caxton Associates (UK)'s PODD Position: Q2 2026 in Review

Caxton Associates (UK) sold out of Insulet (PODD) in Q2 2026, closing a stake of 1,382 shares — an estimated $290K sold.

Caxton Associates (UK) first reported a position in PODD in Q1 2026 and held it in 1 quarter. The position peaked at $290K in Q1 2026. 726 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

Caxton Associates (UK) reported no remaining Insulet position as of Q2 2026 after selling out during the quarter.
Caxton Associates (UK) sold 1,382 Insulet shares in Q2 2026, an estimated $290K.
Caxton Associates (UK) first reported a position in Insulet in Q1 2026 and held it in 1 quarter.
Caxton Associates (UK)'s Insulet position peaked at $290K in Q1 2026.
726 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.